BioMed Research International / 2020 / Article / Tab 1

Review Article

A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries

Table 1

HBsAg prevalence and date of universal vaccination in the different Mediterranean countries.

General population (%)Blood donors (%)HD patients (%)Pregnant women (%)Others (%)Vaccination dateReferences

Morocco1.810.8–0.9661.2ND1999[17, 1922]
Algeria2.153.63.21.6ND2002[2932]
Tunisia4.2–5.60.85.54ND1995[3639]
Libya2.20.212.6ND1.1 (health workers)1993[45, 47, 49, 50]
Egypt1.41.3241.4 (health workers)1992[5257]
Syria4.2ND0.63–2.521.15.3 (drug users) and 10.8 (sex workers)1993[6365]
Lebanon1.74NDNDND0.99 (sex workers) and 2.4 (prisoners)1998[6971]
Palestine/Israel1.75ND3.8NDND1992[44, 74, 75]
France0.650.120.840.65ND1982[7881, 83]
Spain<0.27–1.69ND1.030.80.7 (healthy employed population)1990[8994]
Italy0.8–10.01–0.321.8ND4.4 (prisoners)1981[98, 103106]
Turkey4ND30.2ND2.2 (drug users)1998[113116]
Greece1.2–4.80.84NDNDND1998[121, 122]
Croatia2–40.012NDND7.3 (drug users)1992[128130]

ND: no data.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.